Subtype

Male Reproductive System Neoplasm

Non-malignant1,533 active trials27 approved drugs58 evidence items

NCIt: C3054

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (286)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 1–25 of 286 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Preclinical evaluation of PSMA-targeted ultrasound contrast agents in an orthotopic model of prostate cancer in rabbits.
Felipe M Berg, Eric C Abenojar, Pinunta Nittayacharn et al. · Bioact Mater · Jan 1, 2027 · PMID 42621251 · candidate dictionary pubmed
Daily adaptive 1.5 T MR-Linac image-guided re-irradiation for prostate cancer: an international retrospective experience.
Sian Cooper, Victoria Sarah Brennan, Filippo Alongi et al. · Clin Transl Radiat Oncol · Jan 1, 2027 · PMID 42787873 · candidate dictionary pubmed
Interpretable machine learning for individualized survival prediction in node-positive, non-metastatic prostate cancer: a population-based study.
Erhao Bao, Yucong Chai, Yang Yang et al. · Aging Male · Dec 31, 2026 · PMID 42690326 · candidate dictionary pubmed
Repurposing minocycline to target FOXA1 and its mutants in prostate Cancer.
Ziyin Zhang, Jingwen Xu, Kai Zang et al. · Cell Signal · Dec 1, 2026 · PMID 42636948 · candidate dictionary pubmed
Structure-based screening and identification of a novel Aurora-A-targeting peptide with antiproliferative activity against prostate cancer cells.
Bei-Bei Huang, Haijing Jiang, Yaozhi Hu et al. · J Enzyme Inhib Med Chem · Dec 1, 2026 · PMID 42578512 · candidate dictionary pubmed
Current landscape and emerging trends of PD-1/PD-L1 research in prostate cancer: A data-driven atlas from multidatabase integration.
Bingxin Zhou, Xinyu Ju, Jun Wang et al. · Hum Vaccin Immunother · Dec 1, 2026 · PMID 42710939 · candidate dictionary pubmed

Cryo-EM structure-based discovery of etravirine as a specific inhibitor of PRMT5/pICln protein-protein interaction for prostate cancer treatment.

Zhixia Chi, Xueyong Xu, Zhihang Shen et al. · J Enzyme Inhib Med Chem · Dec 1, 2026 · PMID 42710907 · candidate dictionary pubmed

Water-exchange pharmacokinetic modeling improves DCE-MRI for ROI-based assessment of prostate lesions and of clinically significant prostate cancer.

Zejun Wang, Zhenjie Zang, Yong Li et al. · Magn Reson Imaging · Dec 1, 2026 · PMID 42674229 · candidate dictionary pubmed

Effect of neoadjuvant androgen deprivation therapy on prostate and tumor morphology prior to MRI-guided transurethral ultrasound ablation of prostate cancer.

Ilari Virtanen, Pietari Mäkelä, Teija Sainio et al. · Int J Hyperthermia · Dec 1, 2026 · PMID 42733361 · candidate dictionary pubmed

Short and efficient synthesis of the natural triterpenoids α- and β-amyrins with detailed in silico screening and in vitro anticancer evaluation against breast and prostate cancer cells.

Halil Şenol, Salih Tuncay, Şeyma Ateşoğlu et al. · Comput Biol Chem · Dec 1, 2026 · PMID 42632245 · candidate dictionary pubmed

Aurora kinase a phosphorylates and stabilizes UHRF1 to maintain DNA methylation and prostate cancer cell survival.

Qin Xiang, Yuchong Peng, Yubing Ye et al. · Epigenetics · Dec 1, 2026 · PMID 42789740 · candidate dictionary pubmed

Socioeconomic differences in prostate cancer diagnosis and stage following the introduction of Rapid Access Prostate Clinics in Ireland.

C Haugh, S Walter, P Sweeney et al. · ESMO Real World Data Digit Oncol · Dec 1, 2026 · PMID 42787662 · candidate dictionary pubmed

Identification of Crocin I as a positive modulator of GSTP1 with potential relevance to prostate cancer.

Hao Qin, YuanYuan Wang, Yukai Yang et al. · J Enzyme Inhib Med Chem · Dec 1, 2026 · PMID 42803268 · candidate dictionary pubmed

PSMA binding of carbamate-containing peptidomimetics influenced by side chain length and stereocenter configuration in preclinical prostate cancer model.

Áron Roxin, Helen Merkens, Chengcheng Zhang et al. · Bioorg Med Chem · Nov 1, 2026 · PMID 42623854 · candidate dictionary pubmed

Cotinine enhances androgen receptor stability and promotes androgen-dependent proliferation in prostate cancer cells: An in vitro study.

Riri Hayashi, Yudai Kudo, Yuta Yoshino et al. · Arch Biochem Biophys · Nov 1, 2026 · PMID 42617929 · candidate dictionary pubmed

Phenotypic discovery of a pyrimidine derivative with dual anti-prostate cancer and cardioprotective potential via ROS modulation.

Yaquan Cao, Yaxi Wu, Yunfei Li et al. · Bioorg Med Chem · Nov 1, 2026 · PMID 42612458 · candidate dictionary pubmed

[Expression of Concern] Ganoderma lucidum polysaccharide inhibits prostate cancer cell migration via the protein arginine methyltransferase 6 signaling pathway.

Xiaohui Zhao, Dayu Zhou, Yunen Liu et al. · Mol Med Rep · Nov 1, 2026 · PMID 42725400 · candidate dictionary pubmed

Tumor‑immune spatiotemporal co‑evolution: A new paradigm for understanding and overcoming therapy resistance in metastatic castration‑resistant prostate cancer (Review).

Li Yan, Xiaoke Sun, Pengxiao Su · Int J Mol Med · Nov 1, 2026 · PMID 42788344 · candidate dictionary pubmed

Erratum: [Corrigendum] Antitumour activity of TH1579, a novel MTH1 inhibitor, against castration-resistant prostate cancer.

Mingqiu Hu, Jing Ning, Likai Mao et al. · Oncol Lett · Nov 1, 2026 · PMID 42761412 · candidate dictionary pubmed

Patient-derived models of prostate cancer: Capturing tumour complexity from initiation to metastasis.

Clémentine Le Magnen, W Nathaniel Brennen, Álvaro Aytes et al. · Cancer Lett · Oct 28, 2026 · PMID 42617726 · candidate dictionary pubmed

Predicting disease progression and mortality in prostate cancer using real-world data-driven time-inhomogeneous Markov models.

Jiaqi Wang, Yuanshi Jiao, Dawn Craig et al. · iScience · Oct 16, 2026 · PMID 42781478 · candidate dictionary pubmed

Novel Piperlongumine derivatives exert multimodal antitumor effects in prostate cancer via MAPK pathway activation, poly-mechanistic apoptosis induction, and DNMT3A-mediated DNA methylation reduction.

Yu Zhang, Xue Yang, Xuemei Qiu et al. · Bioorg Chem · Oct 5, 2026 · PMID 42612263 · candidate dictionary pubmed

Expression patterns of potential targets for antibody-directed therapy in metastatic castration-resistant prostate cancer patients.

Tanja C van Dijk, Marcel Smid, Debbie G J Robbrecht et al. · Eur J Cancer · Oct 5, 2026 · PMID 42623835 · candidate dictionary pubmed

Detected Huge Urinoma With 99mTc-PSMA Activity on Initial Prostate Cancer Staging.

Mohammad Ahmadi, Mohammad H Samadi, Amin Saber Tanha et al. · Clin Nucl Med · Oct 1, 2026 · PMID 42710082 · candidate dictionary pubmed

Oncologic Outcomes in a Contemporary "PROTEUS-like" Cohort of High-risk Prostate Cancer Treated with Radical Prostatectomy Without Neoadjuvant Hormonal Therapy.

Can Aydogdu, Benso John, Clara Seizer et al. · Eur Urol Open Sci · Oct 1, 2026 · PMID 42699359 · candidate dictionary pubmed